“…For gnb1 ( gnb1a and gnb1b ): the first set of MOs inhibits translation, as previously validated (Xu et al, 2012), and the individual MOs are referred as gnb1a MO1 (2ng, 5′-GAGTTCGCT CAT TTTCTTCTGCTTC-3′) and gnb1b MO1 (2ng, 5′-CTGGTCCAGTTCACT CAT TTTCCTC-3′), respectively; the second set of MOs inhibits gnb1a translation and blocks gnb1b splicing, as previously validated (Hippe et al, 2009), and the individual MOs are referred as gnb1a MO2 (3ng, 5′-CTGGTCGAGTTCGCT CAT TTTCTTC-3′) and gnb1b MO2 (8ng, 5′-AATTAGGTGGTTACCTGTGATAGT-3′, targets the splice site at the junction between the 1 st exon and intron). For gnb4 ( gnb4a and gnb4b ), the first set of MOs block translation, as previously validated (Xu et al, 2012), and the individual MOs are referred as gnb4a MO1 (4ng, 5′-CCGCAACTGCTC CAGCTCACT CAT G-3′) and gnb4b MO1 (4ng, 5′-GACGCAACTGCTCCAACTCACT CAT -3′); the second set of MOs targets the splicing of gnb4a and gnb4b and the individual MOs are referred as gnb4a MO2 (8ng, 5′-GCATCCTGCAATGGGAACAGCAGCA-3′, targets the splice site at the junction between the 2 nd intron and the 3 rd exon) and gnb4b MO2 (8ng, 5′-TGTTACGGAGTCACCCTTACCCGGA-3′, targets the splice site at the junction between the 2 nd exon and intron). RT-PCR performed on RNA isolated from 28-hpf embryos revealed that embryos injected with gnb4a MO2 or gnb4b MO2 produced smaller amplicons than uninjected control embryos (Fig.…”